FI932553A - Nya farmaceutiska formulationer innehaollande ett farmakologiskt aktivtjoniserbart aemne samt process foer framstaellning daerav - Google Patents

Nya farmaceutiska formulationer innehaollande ett farmakologiskt aktivtjoniserbart aemne samt process foer framstaellning daerav Download PDF

Info

Publication number
FI932553A
FI932553A FI932553A FI932553A FI932553A FI 932553 A FI932553 A FI 932553A FI 932553 A FI932553 A FI 932553A FI 932553 A FI932553 A FI 932553A FI 932553 A FI932553 A FI 932553A
Authority
FI
Finland
Prior art keywords
pharmaceutical formulation
pharmacologically active
active substance
same process
substance
Prior art date
Application number
FI932553A
Other languages
English (en)
Other versions
FI932553A0 (fi
Inventor
Bengt Lindstedt
Per Johan Gunnar Lundberg
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of FI932553A publication Critical patent/FI932553A/fi
Publication of FI932553A0 publication Critical patent/FI932553A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI932553A 1990-12-07 1993-06-04 Nya farmaceutiska formulationer innehaollande ett farmakologiskt aktivtjoniserbart aemne samt process foer framstaellning daerav FI932553A0 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003903A SE9003903D0 (sv) 1990-12-07 1990-12-07 New pharmaceutical formulations

Publications (2)

Publication Number Publication Date
FI932553A true FI932553A (fi) 1993-06-04
FI932553A0 FI932553A0 (fi) 1993-06-04

Family

ID=20381122

Family Applications (1)

Application Number Title Priority Date Filing Date
FI932553A FI932553A0 (fi) 1990-12-07 1993-06-04 Nya farmaceutiska formulationer innehaollande ett farmakologiskt aktivtjoniserbart aemne samt process foer framstaellning daerav

Country Status (17)

Country Link
US (2) US5707656A (fi)
EP (1) EP0560816B1 (fi)
JP (1) JP3276956B2 (fi)
AT (1) ATE444737T1 (fi)
AU (1) AU656346B2 (fi)
CA (1) CA2097176C (fi)
DE (1) DE69133623D1 (fi)
EE (1) EE03105B1 (fi)
FI (1) FI932553A0 (fi)
HU (1) HU218661B (fi)
IE (1) IE914136A1 (fi)
IS (1) IS1749B (fi)
NO (1) NO305536B1 (fi)
PT (1) PT99720B (fi)
SE (1) SE9003903D0 (fi)
WO (1) WO1992010171A1 (fi)
YU (1) YU186791A (fi)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU736308B2 (en) * 1996-12-20 2001-07-26 Warner-Lambert Company Llc Antitussive drugs delivered by ion exchange resins
WO2001008661A2 (en) * 1999-07-29 2001-02-08 Roxane Laboratories, Inc. Opioid sustained-released formulation
US20030118641A1 (en) * 2000-07-27 2003-06-26 Roxane Laboratories, Inc. Abuse-resistant sustained-release opioid formulation
KR20030034171A (ko) * 2001-07-06 2003-05-01 엔도 파마슈티걸즈, 인크. 옥시모르폰 제어 방출 제형
US20030099711A1 (en) * 2001-08-29 2003-05-29 David Meadows Sustained release preparations
EP1499295A4 (en) * 2002-04-05 2006-04-05 Penwest Pharmaceuticals Co EXTENDED RELEASE METOPROLOL FORMULATIONS
US7314640B2 (en) * 2003-07-11 2008-01-01 Mongkol Sriwongjanya Formulation and process for drug loaded cores
US20050265955A1 (en) * 2004-05-28 2005-12-01 Mallinckrodt Inc. Sustained release preparations
JP2006296511A (ja) * 2005-04-15 2006-11-02 Transcutaneous Technologies Inc 外用剤、外用剤の塗布方法、イオントフォレーシス装置及び経皮パッチ
JP2006346368A (ja) * 2005-06-20 2006-12-28 Transcutaneous Technologies Inc イオントフォレーシス装置及びその製造方法
US20090214625A1 (en) * 2005-07-15 2009-08-27 Mizuo Nakayama Drug delivery patch
JP2007037868A (ja) * 2005-08-05 2007-02-15 Transcutaneous Technologies Inc 経皮投与装置及びその制御方法
US8386030B2 (en) * 2005-08-08 2013-02-26 Tti Ellebeau, Inc. Iontophoresis device
US20070060860A1 (en) * 2005-08-18 2007-03-15 Transcutaneous Technologies Inc. Iontophoresis device
WO2007026671A1 (ja) * 2005-08-29 2007-03-08 Transcu Ltd. センサからの情報により投与すべき薬剤の選定を行うイオントフォレーシス装置
AU2006289888B2 (en) * 2005-09-16 2010-12-02 Tti Ellebeau, Inc. Catheter type iontophoresis apparatus
US20070071807A1 (en) * 2005-09-28 2007-03-29 Hidero Akiyama Capsule-type drug-releasing device and capsule-type drug-releasing device system
WO2007038028A1 (en) * 2005-09-28 2007-04-05 Tti Ellebeau, Inc. Iontophoresis apparatus and method to deliver active agents to biological interfaces
EP1941929A1 (en) * 2005-09-30 2008-07-09 Tti Ellebeau, Inc. Electrode structure for iontophoresis comprising shape memory separator, and iontophoresis apparatus comprising the same
CN101277737A (zh) * 2005-09-30 2008-10-01 Tti优而美株式会社 将多种活性剂输送至生物界面的离子电渗装置
US20090187134A1 (en) * 2005-09-30 2009-07-23 Hidero Akiyama Iontophoresis Device Controlling Amounts of a Sleep-Inducing Agent and a Stimulant to be Administered and Time at Which the Drugs are Administered
US20070197955A1 (en) * 2005-10-12 2007-08-23 Transcutaneous Technologies Inc. Mucous membrane adhesion-type iontophoresis device
US20080193514A1 (en) * 2006-11-02 2008-08-14 Transcu Ltd. Compostions and methods for iontophoresis delivery of active ingredients through hair follicles
EP2123259A1 (en) * 2007-01-16 2009-11-25 Hokkaido University Liposome preparation for iontophoresis having antioxidant component encapsulated therein
JP2010187707A (ja) * 2007-06-12 2010-09-02 Hokkaido Univ インスリンを封入したイオントフォレーシス用リポソーム製剤
MX2011002529A (es) * 2008-09-10 2011-07-29 Transcu Ltd Aparato y metodo para suministrar liquidos viscosos basados en hpc dentro de substratos porosos, por ejemplo un proceso basado en una banda continua.
WO2010115015A1 (en) * 2009-04-03 2010-10-07 Coating Place, Inc. Modified-release pharmaceutical drug composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983392A (en) * 1983-11-14 1991-01-08 Bio-Mimetics, Inc. Bioadhesive compositions and methods of treatment therewith
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
EP0199855A1 (en) * 1985-05-02 1986-11-05 Gist-Brocades N.V. Tablets comprising tromethoprim and a sulfonamide
JPS62223112A (ja) * 1986-03-25 1987-10-01 Rooto Seiyaku Kk 歯周病治療剤
IE62100B1 (en) * 1986-07-30 1994-12-14 Fisons Corp Coated ion exchange resins
DE3740684A1 (de) * 1987-12-01 1989-06-15 Woehr Otto Gmbh Parksystem
MC2025A1 (fr) * 1988-04-20 1990-04-25 Asta Pharma Ag Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it
CA2002492A1 (en) * 1988-11-11 1990-05-11 Sandra T. A. Malkowska Pharmaceutical ion exchange resin composition
US5149523A (en) * 1989-06-20 1992-09-22 Aktiebolaget Hassle Polystyrenesulfonate-drug complex and solid dosage forms thereof

Also Published As

Publication number Publication date
ATE444737T1 (de) 2009-10-15
HUT64213A (en) 1993-12-28
CA2097176C (en) 2002-03-26
YU186791A (sh) 1994-04-05
HU218661B (hu) 2000-10-28
PT99720A (pt) 1992-10-30
US5707656A (en) 1998-01-13
PT99720B (pt) 2002-04-29
EP0560816A1 (en) 1993-09-22
NO305536B1 (no) 1999-06-21
IS3787A7 (is) 1992-06-08
FI932553A0 (fi) 1993-06-04
JP3276956B2 (ja) 2002-04-22
WO1992010171A1 (en) 1992-06-25
AU656346B2 (en) 1995-02-02
CA2097176A1 (en) 1992-06-08
NO932053D0 (no) 1993-06-04
HU9301671D0 (en) 1993-09-28
EP0560816B1 (en) 2009-10-07
AU8930591A (en) 1992-07-08
US5709882A (en) 1998-01-20
JPH06503311A (ja) 1994-04-14
IE914136A1 (en) 1992-06-17
DE69133623D1 (de) 2009-11-19
IS1749B (is) 2000-07-11
NO932053L (no) 1993-07-20
EE03105B1 (et) 1998-08-17
SE9003903D0 (sv) 1990-12-07

Similar Documents

Publication Publication Date Title
FI932553A (fi) Nya farmaceutiska formulationer innehaollande ett farmakologiskt aktivtjoniserbart aemne samt process foer framstaellning daerav
ES2045229T3 (es) Pirrolidinas 1,3-disubstituidas.
FI914607A0 (fi) Farmaceutisk blandning i gelform i en dispenserfoerpackning.
PT88404A (pt) Dosage form comprising fast agent delivery followed by slow agent delivery
YU174490A (sh) Novi estri tienil-karboksilne kiseline sa aminoalkoholima, njihova kvaterna jedinjenja kao i pripremanje i primena tih jedinjenja
ES2052829T3 (es) Aminoetiltetralinas substituidas asi como sus analogos heterociclicos.
DK0532525T3 (da) Nye protein-polykationkonjugater
NL193907B (nl) Basische ether en farmaceutische samenstelling die de basische ether als actief bestanddeel bevat.
ES2134189T3 (es) Procedimiento para la preparacion de un producto de celulosa oxidado neutralizado y uso del mismo.
FI820808L (fi) Stabiliserade insulinpreparat och foerfarande foer framstaellning av dessa
DK0957981T3 (da) Rersorvoirer til aflevering af lægemidler ved elektrotransport, indeholdende inerte fyldmaterialer
DE69119810D1 (de) Pyrogensorbentmittel
SE420049B (sv) Forfarande for framstellning av en losning av ett stabilt humanplasmaprotein, vilket ej visar blodtryckssenkande verkan
BE885756A (fr) Mono (2-ammonium-2-hydroxymethyl-1,3-propanediol)(2r-cis)-(3-methyloxiranyl)phosphonate, sa preparation et compositions pharmaceutiques en contenant
ES2019634B3 (es) Terapia con clorfeniramina.
SE9902742D0 (sv) New pharmaceutical formultion
FI920428A0 (fi) Ett podofyllotoxinpreparat som innehaoller triglyserider.
ES415323A1 (es) Procedimiento para metilizar cefalina y serincefalina.
BR9813037A (pt) Composto, processo para sua preparação, uso do mesmo, preparação farmacêutica, e, combinação desta com pelo menos uma outra substância ativa
AU476756B2 (en) PHARMACOLOGICALLY ACTIVE 4, 8-DIMETHOXY-FURO-(3',2'-F) BENZOXAZOL-2-yl ACETHYDROXAMIC ACID
GR3002665T3 (en) Use of nitrophenyl groups for stimulating the capability of incorporation of a drug into the sensitive cells of a host
HU886315D0 (en) Process for the production of pharmaceutical preparations for curing hyperlipaemia, containing oxoquinazoline derivatives as active agents
IT8609429A0 (it) Utilizzazione della forma farmaceutica 'gel'contenente acido n (2,6 dicloro m tolil) antranilico (acido meclofenamico) impiegabile in terapia per uso topico.
IT8622051A1 (it) Composizioni farmaceutiche ad attivita' cicatrizzante
SE442478B (sv) Forfarande for framstellning av en farmaceutisk komposition eller injektionslosning vilken komposition innefattar natriumamoxycillin och trinatriumfosfat ev upplost i ett vattenhaltigt losningsmedel